Back to Search Start Over

Ixabepilone.

Authors :
Conlin, Alison
Fornier, Monica
Hudis, Clifford
Kar, Santwana
Kirkpatrick, Peter
Source :
Nature Reviews Drug Discovery; Dec2007, Vol. 6 Issue 12, p953-954, 2p, 1 Color Photograph, 1 Diagram
Publication Year :
2007

Abstract

Ixabepilone (Ixempra; Bristol-Myers Squibb), a cytotoxic microtubule inhibitor, was approved by the US FDA for the treatment of metastatic breast cancer in October 2007. It is the first member of the epothilone family of anticancer agents to be approved. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14741776
Volume :
6
Issue :
12
Database :
Complementary Index
Journal :
Nature Reviews Drug Discovery
Publication Type :
Academic Journal
Accession number :
27666726
Full Text :
https://doi.org/10.1038/nrd2469